REFRACTORY CERAMIC FIBRE FELT

Hazard statements (CLP)

H317, H319, H335, H350, H372

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause cancer. Causes damage to organs through prolonged or repeated exposure. May cause respiratory irritation. May cause an allergic skin reaction. Causes serious eye irritation

Hazard pictograms

GHS07 GHS08

Signal word

Danger

Contains

ALUMINOSILICATE; PHENOL-FORMALDEHYDE RESIN (CURED)

Hazard statements

H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. H350 - May cause cancer. H372 - Causes damage to organs through prolonged or repeated exposure.

Precautionary statements

P201 - Obtain special instructions before use. P261 - Avoid breathing dust. P280 - Wear eye protection, protective clothing, protective gloves. P308+P313 - IF exposed or concerned: Get medical advice/attention. P312 - Call a POISON CENTER, doctor if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label).

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component ALUMINOSILICATE (142844-00-6) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component ALUMINOSILICATE (142844-00-6) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 1A H350 Specific target organ toxicity – Single exposure, Category 3, Respiratory H335 tract irritation Specific target organ toxicity – Repeated exposure, Category 1 H372 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause cancer. Causes damage to organs through prolonged or repeated exposure. May cause respiratory irritation. May cause an allergic skin reaction. Causes serious eye irritation.